Crossref journal-article
Elsevier BV
Neurobiology of Disease (78)
Bibliography

Nakamori, M., & Thornton, C. (2010). Epigenetic changes and non-coding expanded repeats. Neurobiology of Disease, 39(1), 21–27.

Authors 2
  1. Masayuki Nakamori (first)
  2. Charles Thornton (additional)
References 113 Referenced 29
  1. 10.1093/hmg/ddm346 / Hum. Mol. Genet. / The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues by Al-Mahdawi (2008)
  2. 10.1093/hmg/8.11.1975 / Hum. Mol. Genet. / Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model by Amack (1999)
  3. 10.1111/j.1471-4159.2009.06302.x / J. Neurochem. / The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies by Bauer (2009)
  4. 10.1016/j.tins.2004.04.009 / Trends Neurosci. / The mGluR theory of fragile X mental retardation by Bear (2004)
  5. 10.1086/301680 / Am. J. Hum. Genet. / The GAA triplet-repeat expansion in Friedreich ataxia interferes with transcription and may be associated with an unusual DNA structure by Bidichandani (1998)
  6. 10.1016/0092-8674(92)90154-5 / Cell / Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member by Brook (1992)
  7. 10.1126/science.271.5254.1423 / Science / Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion by Campuzano (1996)
  8. 10.1093/hmg/6.11.1771 / Hum. Mol. Genet. / Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes by Campuzano (1997)
  9. 10.1016/S1097-2765(02)00572-5 / Mol. Cell / Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing by Charlet-B (2002)
  10. 10.1016/j.molcel.2005.09.002 / Mol. Cell / Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF by Cho (2005)
  11. 10.1038/8807 / Nat. Genet. / Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells by Coffee (1999)
  12. 10.1086/342931 / Am. J. Hum. Genet. / Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome by Coffee (2002)
  13. 10.1074/jbc.M410781200 / J. Biol. Chem. / MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1 by Dansithong (2005)
  14. 10.1016/S0092-8674(01)00566-9 / Cell / Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function by Darnell (2001)
  15. 10.1073/pnas.94.14.7388 / Proc. Natl. Acad. Sci. USA / Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts by Davis (1997)
  16. 10.1371/journal.pone.0007914 / PLoS ONE / Epigenetic silencing in Friedreich ataxia is associated with depletion of CTCF (CCCTC-binding factor) and antisense transcription by De Biase (2009)
  17. 10.1038/ng0193-31 / Nat. Genet. / A point mutation in the FMR-1 gene associated with fragile X mental retardation by De Boulle (1993)
  18. 10.1093/hmg/ddl137 / Hum. Mol. Genet. / MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1 by de Haro (2006)
  19. 10.1136/jmg.2008.064667 / J. Med. Genet. / Fragile X syndrome: from molecular genetics to therapy by D'Hulst (2009)
  20. 10.1038/nrg1690 / Nat. Rev. Genet. / Therapeutics development for triplet repeat expansion diseases by Di Prospero (2005)
  21. 10.1038/nsmb.1720 / Nat. Struct. Mol. Biol. / Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy by Du (2010)
  22. 10.1093/hmg/11.7.805 / Hum. Mol. Genet. / Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells by Fardaei (2002)
  23. 10.1126/science.7732383 / Science / Translational suppression by trinucleotide repeat expansion at FMR1 by Feng (1995)
  24. 10.1038/ng570 / Nat. Genet. / CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus by Filippova (2001)
  25. {'key': '10.1016/j.nbd.2010.02.004_bib25', 'first-page': '554', 'article-title': 'The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia', 'volume': '59', 'author': 'Filla', 'year': '1996', 'journal-title': 'Am. J. Hum. Genet.'} / Am. J. Hum. Genet. / The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia by Filla (1996)
  26. 10.1038/sj.gt.3301955 / Gene Ther. / Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions by Furling (2003)
  27. 10.1038/ejhg.2008.61 / Eur. J. Hum. Genet. / Fragile X syndrome by Garber (2008)
  28. 10.1021/ja804398y / J. Am. Chem. Soc. / Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA–MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1) by Gareiss (2008)
  29. 10.1038/nrg1691 / Nat. Rev. Genet. / Diseases of unstable repeat expansion: mechanisms and common principles by Gatchel (2005)
  30. 10.1038/ng0892-341 / Nat. Genet. / Fragile X syndrome without CCG amplification has an FMR1 deletion by Gedeon (1992)
  31. 10.1093/nar/gkh612 / Nucleic Acids Res. / Chemically induced increases and decreases in the rate of expansion of a CAG*CTG triplet repeat by Gomes-Pereira (2004)
  32. 10.1093/nar/28.14.2815 / Nucleic Acids Res. / The GAA*TTC triplet repeat expanded in Friedreich's ataxia impedes transcription elongation by T7 RNA polymerase in a length and supercoil dependent manner by Grabczyk (2000)
  33. 10.1093/brain/awf184 / Brain / Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers by Greco (2002)
  34. 10.1093/nar/gkm271 / Nucleic Acids Res. / Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia by Greene (2007)
  35. 10.1086/386296 / Am. J. Hum. Genet. / The fragile-X premutation: a maturing perspective by Hagerman (2004)
  36. 10.1212/WNL.57.1.127 / Neurology / Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X by Hagerman (2001)
  37. 10.1073/pnas.94.14.7394 / Proc. Natl. Acad. Sci. USA / Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes by Hamshere (1997)
  38. {'key': '10.1016/j.nbd.2010.02.004_bib38', 'series-title': 'Myotonic Dystrophy', 'author': 'Harper', 'year': '2001'} / Myotonic Dystrophy by Harper (2001)
  39. 10.1038/nchembio815 / Nat. Chem. Biol. / Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia by Herman (2006)
  40. 10.1038/sj.emboj.7600300 / EMBO J. / Muscleblind proteins regulate alternative splicing by Ho (2004)
  41. 10.1093/hmg/ddi162 / Hum. Mol. Genet. / Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy by Ho (2005)
  42. 10.1073/pnas.122205699 / Proc. Natl. Acad. Sci. USA / Altered synaptic plasticity in a mouse model of fragile X mental retardation by Huber (2002)
  43. 10.1136/jmg.29.11.774 / J. Med. Genet. / The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy by Hunter (1992)
  44. 10.1086/374321 / Am. J. Hum. Genet. / Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates by Jacquemont (2003)
  45. 10.1016/S1474-4422(06)70676-7 / Lancet Neurol. / Fragile-X syndrome and fragile X-associated tremor/ataxia syndrome: two faces of FMR1 by Jacquemont (2007)
  46. 10.1038/ng0796-316 / Nat. Genet. / Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice by Jansen (1996)
  47. 10.1093/hmg/ddh327 / Hum. Mol. Genet. / Myotonic dystrophy type 1 associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins, and deregulated alternative splicing in neurons by Jiang (2004)
  48. 10.1016/S0896-6273(03)00533-6 / Neuron / RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila by Jin (2003)
  49. 10.1016/j.neuron.2007.07.020 / Neuron / Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome by Jin (2007)
  50. 10.1126/science.1088583 / Science / A muscleblind knockout model for myotonic dystrophy by Kanadia (2003)
  51. 10.1016/S1567-133X(03)00064-4 / Gene Expr. Patterns / Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3 by Kanadia (2003)
  52. 10.1073/pnas.0604970103 / Proc. Natl. Acad. Sci. USA / Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy by Kanadia (2006)
  53. 10.1093/hmg/10.14.1449 / Hum. Mol. Genet. / Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers by Kenneson (2001)
  54. 10.1038/ng0897-402 / Nat. Genet. / Trinucleotide repeat expansion at the myotonic dystrophy locus reduces expression of the DMAHP gene by Klesert (1997)
  55. 10.1038/75490 / Nat. Genet. / Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy by Klesert (2000)
  56. 10.1006/geno.1995.1099 / Genomics / Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing by Krahe (1995)
  57. 10.1016/j.molcel.2007.07.027 / Mol. Cell / Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation by Kuyumcu-Martinez (2007)
  58. 10.1093/hmg/ddm293 / Hum. Mol. Genet. / An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals by Ladd (2007)
  59. 10.1016/S1525-0016(03)00068-6 / Mol. Ther. / Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts by Langlois (2003)
  60. 10.1074/jbc.M501591200 / J. Biol. Chem. / Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells by Langlois (2005)
  61. 10.1093/hmg/ddl132 / Hum. Mol. Genet. / Failure of MBNL1-dependent postnatal splicing transitions in myotonic dystrophy by Lin (2006)
  62. 10.1126/science.1062125 / Science / Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9 by Liquori (2001)
  63. 10.1085/jgp.200609635 / J. Gen. Physiol. / Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy by Lueck (2007)
  64. 10.1126/science.289.5485.1769 / Science / Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat by Mankodi (2000)
  65. 10.1016/S1097-2765(02)00563-4 / Mol. Cell / Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy by Mankodi (2002)
  66. 10.1093/hmg/ddl103 / Hum. Mol. Genet. / DM2 intronic expansions: evidence for CCUG accumulation without flanking sequence or effects on ZNF9 mRNA processing or protein expression by Margolis (2006)
  67. 10.1038/sj.emboj.7600545 / EMBO J. / The profile of repeat-associated histone lysine methylation states in the mouse epigenome by Martens (2005)
  68. 10.1093/emboj/19.17.4439 / EMBO J. / Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy by Miller (2000)
  69. 10.1073/pnas.0905780106 / Proc. Natl. Acad. Sci. USA / Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy by Mulders (2009)
  70. 10.1101/gr.74502 / Genome Res. / CpG methylation modifies the genetic stability of cloned repeat sequences by Nichol (2002)
  71. 10.1073/pnas.0708519105 / Proc. Natl. Acad. Sci. USA / Expanded CTG repeats within the DMPK 3′ UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy by Orengo (2008)
  72. 10.1146/annurev.neuro.29.051605.113042 / Annu. Rev. Neurosci. / Trinucleotide repeat disorders by Orr (2007)
  73. 10.1093/hmg/ddp058 / Hum. Mol. Genet. / Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy by Osborne (2009)
  74. 10.1073/pnas.92.12.5465 / Proc. Natl. Acad. Sci. USA / Triplet repeat expansion in myotonic dystrophy alters the adjacent chromatin structure by Otten (1995)
  75. 10.1001/archneur.65.10.1296 / Arch. Neurol. / Friedreich ataxia by Pandolfo (2008)
  76. 10.1038/nrg1689 / Nat. Rev. Genet. / Repeat instability: mechanisms of dynamic mutations by Pearson (2005)
  77. 10.1126/science.280.5364.737 / Science / Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy by Philips (1998)
  78. 10.1016/0092-8674(91)90125-I / Cell / Absence of expression of the FMR-1 gene in fragile X syndrome by Pieretti (1991)
  79. 10.1093/nar/gkf434 / Nucleic Acids Res. / Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine by Pietrobono (2002)
  80. 10.1093/hmg/ddi024 / Hum. Mol. Genet. / Molecular dissection of the events leading to inactivation of the FMR1 gene by Pietrobono (2005)
  81. 10.1021/ja9020149 / J. Am. Chem. Soc. / Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3 by Pushechnikov (2009)
  82. 10.1371/journal.pone.0001958 / PLoS ONE / HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model by Rai (2008)
  83. 10.1038/ng0796-325 / Nat. Genet. / Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy by Reddy (1996)
  84. 10.1016/S1097-2765(00)80474-8 / Mol. Cell / Sticky DNA: self-association properties of long GAA.TTC repeats in R.R.Y triplex structures from Friedreich's ataxia by Sakamoto (1999)
  85. 10.1038/75500 / Nat. Genet. / Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts by Sarkar (2000)
  86. 10.1038/nature01596 / Nature / DNA triplet repeats mediate heterochromatin-protein-1-sensitive variegated gene silencing by Saveliev (2003)
  87. 10.1038/ng704 / Nat. Genet. / Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy by Savkur (2001)
  88. 10.1093/hmg/10.23.2717 / Hum. Mol. Genet. / Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities by Seznec (2001)
  89. 10.1093/hmg/ddm213 / Hum. Mol. Genet. / Polyglutamine diseases: emerging concepts in pathogenesis and therapy by Shao (2007)
  90. 10.1083/jcb.200706048 / J. Cell Biol. / Defining early steps in mRNA transport: mutant mRNA in myotonic dystrophy type I is blocked at entry into SC-35 domains by Smith (2007)
  91. 10.1089/oli.1.1997.7.187 / Antisense Nucleic Acid Drug Dev. / Morpholino antisense oligomers: design, preparation, and properties by Summerton (1997)
  92. 10.1093/hmg/1.6.397 / Hum. Mol. Genet. / DNA methylation represses FMR-1 transcription in fragile X syndrome by Sutcliffe (1992)
  93. 10.1083/jcb.128.6.995 / J. Cell Biol. / Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues by Taneja (1995)
  94. 10.1086/302720 / Am. J. Hum. Genet. / Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome by Tassone (2000)
  95. 10.1136/jmg.2003.012518 / J. Med. Genet. / Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome by Tassone (2004)
  96. 10.4161/rna.1.2.1035 / RNA Biol. / FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS) by Tassone (2004)
  97. 10.1002/(SICI)1096-8628(19990528)84:3<233::AID-AJMG14>3.0.CO;2-6 / Am. J. Med. Genet. / Tissue heterogeneity of the FMR1 mutation in a high-functioning male with fragile X syndrome by Taylor (1999)
  98. 10.1038/ng0897-407 / Nat. Genet. / Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene by Thornton (1997)
  99. 10.1128/MCB.21.20.6927-6938.2001 / Mol. Cell. Biol. / Molecular basis for impaired muscle differentiation in myotonic dystrophy by Timchenko (2001)
  100. 10.1074/jbc.M312923200 / J. Biol. Chem. / Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis by Timchenko (2004)
  101. 10.1038/ng0692-192 / Nat. Genet. / Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy by Tsilfidis (1992)
  102. 10.1016/0092-8674(91)90397-H / Cell / Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome by Verkerk (1991)
  103. 10.1172/JCI32308 / J. Clin. Invest. / Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy by Wang (2007)
  104. 10.1261/rna.610607 / RNA / MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T by Warf (2007)
  105. 10.1073/pnas.0903234106 / Proc. Natl. Acad. Sci. USA / Pentamidine reverses the splicing defects associated with myotonic dystrophy by Warf (2009)
  106. 10.1126/science.1173110 / Science / Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA by Wheeler (2009)
  107. 10.1093/hmg/ddg114 / Hum. Mol. Genet. / The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome by Willemsen (2003)
  108. 10.1016/j.tins.2008.07.004 / Trends Neurosci. / Polyglutamine neurodegeneration: protein misfolding revisited by Williams (2008)
  109. 10.1038/ng0693-140 / Nat. Genet. / Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion by Wohrle (1993)
  110. 10.1136/jmg.35.2.103 / J. Med.Genet. / Unusual mutations in high functioning fragile X males: apparent instability of expanded unmethylated CGG repeats by Wohrle (1998)
  111. 10.1016/j.chembiol.2009.07.010 / Chem. Biol. / Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencing by Xu (2009)
  112. 10.1086/379523 / Am. J. Hum. Genet. / Replication inhibitors modulate instability of an expanded trinucleotide repeat at the myotonic dystrophy type 1 disease locus in human cells by Yang (2003)
  113. 10.1093/nar/gkm601 / Nucleic Acids Res. / Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs by Yuan (2007)
Dates
Type When
Created 15 years, 6 months ago (Feb. 22, 2010, 7:04 a.m.)
Deposited 6 years, 8 months ago (Dec. 12, 2018, 9:54 p.m.)
Indexed 4 months, 4 weeks ago (March 31, 2025, 7:43 a.m.)
Issued 15 years, 1 month ago (July 1, 2010)
Published 15 years, 1 month ago (July 1, 2010)
Published Print 15 years, 1 month ago (July 1, 2010)
Funders 0

None

@article{Nakamori_2010, title={Epigenetic changes and non-coding expanded repeats}, volume={39}, ISSN={0969-9961}, url={http://dx.doi.org/10.1016/j.nbd.2010.02.004}, DOI={10.1016/j.nbd.2010.02.004}, number={1}, journal={Neurobiology of Disease}, publisher={Elsevier BV}, author={Nakamori, Masayuki and Thornton, Charles}, year={2010}, month=jul, pages={21–27} }